• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2020 Aug 31;202008281.
doi: 10.1073/pnas.2008281117. Online ahead of print.
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants


Bethany Dearlove[SUP] 1 2 3 4 [/SUP], Eric Lewitus[SUP] 1 2 3 4 [/SUP], Hongjun Bai[SUP] 1 2 3 4 [/SUP], Yifan Li[SUP] 1 2 3 4 [/SUP], Daniel B Reeves[SUP] 5 [/SUP], M Gordon Joyce[SUP] 1 3 [/SUP], Paul T Scott[SUP] 1 [/SUP], Mihret F Amare[SUP] 1 3 [/SUP], Sandhya Vasan[SUP] 2 3 4 [/SUP], Nelson L Michael[SUP] 4 [/SUP], Kayvon Modjarrad[SUP] 6 4 [/SUP], Morgane Rolland[SUP] 6 2 3 4 [/SUP]



Affiliations

Abstract

The magnitude of the COVID-19 pandemic underscores the urgency for a safe and effective vaccine. Many vaccine candidates focus on the Spike protein, as it is targeted by neutralizing antibodies and plays a key role in viral entry. Here we investigate the diversity seen in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences and compare it to the sequence on which most vaccine candidates are based. Using 18,514 sequences, we perform phylogenetic, population genetics, and structural bioinformatics analyses. We find limited diversity across SARS-CoV-2 genomes: Only 11 sites show polymorphisms in >5% of sequences; yet two mutations, including the D614G mutation in Spike, have already become consensus. Because SARS-CoV-2 is being transmitted more rapidly than it evolves, the viral population is becoming more homogeneous, with a median of seven nucleotide substitutions between genomes. There is evidence of purifying selection but little evidence of diversifying selection, with substitution rates comparable across structural versus nonstructural genes. Finally, the Wuhan-Hu-1 reference sequence for the Spike protein, which is the basis for different vaccine candidates, matches optimized vaccine inserts, being identical to an ancestral sequence and one mutation away from the consensus. While the rapid spread of the D614G mutation warrants further study, our results indicate that drift and bottleneck events can explain the minimal diversity found among SARS-CoV-2 sequences. These findings suggest that a single vaccine candidate should be efficacious against currently circulating lineages.

Keywords: SARS-CoV-2; evolution; vaccine.
 
Back
Top Bottom